Patient expectations for placebo treatments commonly used in osteopathic manipulative treatment (OMT) clinical trials: a pilot study by Fulda, Kimberly G et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Osteopathic Medicine and Primary 
Care
Open Access Research
Patient expectations for placebo treatments commonly used in 
osteopathic manipulative treatment (OMT) clinical trials: a pilot 
study
Kimberly G Fulda*, Turner Slicho and Scott T Stoll
Address: Osteopathic Research Center, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA
Email: Kimberly G Fulda* - kfulda@hsc.unt.edu; Turner Slicho - tslicho@hsc.unt.edu; Scott T Stoll - sstoll@hsc.unt.edu
* Corresponding author    
Background: Placebo treatments should be believable to ensure expectation of benefit, yet not
provide a true treatment effect. One obstacle to conducting clinical trials with osteopathic
manipulative treatment (OMT) is choosing an appropriate placebo. Various placebo treatments
have been used in OMT clinical trials. The purpose of this study was to determine expectations of
3 treatments (HVLA, placebo light touch, placebo sub-therapeutic ultrasound) commonly used in
OMT clinical research trials.
Methods: A randomized, cross-over design was utilized. Subjects were recruited from the Family
Medicine Clinic, Texas College of Osteopathic Medicine. Participants watched a video with 2
minute demonstrations of a High Velocity Low Amplitude (HVLA), placebo light touch (LT), and
placebo sub-therapeutic ultrasound (ULTRA) treatment for low back pain. The order of
presentations was randomized to control for order effect bias. Subjects indicated the extent of
their agreement (using a 4 point Likert scale) with 4 statements that were presented after each
treatment was viewed: 1)I believe this treatment would allow me to get better quicker; 2)I believe
this treatment would decrease my low back pain; 3)I believe this treatment would make me more
able to do the things I want to do; 4)This seems like a logical way to treat low back pain. Repeated
measures analysis of variance was performed, and a partial Eta squared was calculated for each
statement. Effect sizes (Cohen's d) were calculated where appropriate.
Results: Thirty of 40 eligible subjects participated. Twenty-two (73%) were female, 16 (53%) were
Caucasian, and 11 (37%) had completed college. The mean age was 43 (SD = 15.). Repeated
measures ANOVA revealed no significant differences for statements 2 and 4. For both statements
1 (p = 0.025) and 3 (p = 0.039), post hoc analysis revealed a difference between HVLA and LT. The
partial Eta squared (ηp
2) was 0.105, 0.072, 0.107, and 0.024 for each statement, respectively.
Conclusion: There is a difference in treatment expectation between HVLA and LT for statements
1 and 3. Participants responded more positively after viewing the HVLA treatment than the LT
treatment. This suggests that sub-therapeutic ultrasound is the better placebo because the
expectations were similar to those for HVLA.
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Background
Randomized controlled trials (RCTs) are considered the
most rigorous form of research and are commonly used to
evaluate the effectiveness of medical interventions. An
RCT compares an intervention to either a placebo, gold
standard, or both. Selecting the optimal placebo group is
essential for valid comparison between groups and to
measure the effectiveness of an intervention. A placebo
treatment should be believable to ensure expectation of
benefit, yet not provide a true treatment effect [1,2]. Thus,
to a subject in a pharmaceutical clinical trial, the placebo
treatment should appear indistinguishable from the active
treatment.
Several definitions have been used to define placebo. The
strictest traditional interpretation of the definition would
limit the use of a placebo to only pharmaceutical trials
using sugar pills as the placebo treatment. Such a defini-
tion is not useful in clinical trials of non-pharmaceutical
interventions such as manipulative treatment. One defini-
tion of placebo that attempts to incorporate non-pharma-
ceutical interventions is "a substance or procedure that
has no inherent power to produce an effect that is sought
or expected" [3]. McQuay and Moore more broadly define
placebo effect as "the effect that we observe when patients
are given a placebo," or "the effect caused by placebo" [4].
Hróbjartsson suggests there are three main elements of
placebo effect including: change after placebo medication
(pre/post change in placebo group), effect of placebo
intervention (treatment experience), and effect of patient
– provider interaction [5]. The term placebo response is
often used interchangeably with placebo effect.
There are two prominent theories for why the placebo
effect exists. The conditioning theory suggests that when
pairing a neutral stimulus with an unconditioned stimu-
lus (such as the active drug) the neutral stimulus elicits a
response, resulting in a conditioned response [6]. In con-
trast, the expectancy theory is based on the patient expec-
tations. The response to a stimulus depends on what
response is expected from the stimulus. These patient
expectations may not account for all of the placebo effect,
but they are the most significant factor of the expectancy
theory [3].
A common misconception about placebos is that a third
of the population will demonstrate a placebo response.
This is not always the case. McQuay and Moore found that
placebo response varies from 7% for pain treatment of
migraines to 49% for pain treatment of diabetic neuropa-
thy [4]. The response to placebos in clinical research trials
differs according to the length of the trial, the medical
condition studied, the placebo used, and various other
factors [7]. Patient-physician interaction plays a role in
placebo response. For example, a physician's attitude
(enthusiastic versus doubtful) towards an intervention
can significantly influence a patient's health outcomes
such as pain, psychiatric illness, hypertension, and obesity
[8].
The informed consent process also affects the placebo
response. In one clinical trial, cancer patients not needing
major analgesics were given either naproxen or a placebo
for pain. Some of the patients were informed that they
were participating in a clinical trial and would receive
either naproxen or a placebo, while others were not
informed about the trial. The patients who were informed
of the possibility of receiving a placebo and actually
received the placebo had greater pain relief than those
patients who were not informed of the trial and were
given naproxen [9]. Additionally, the active drug to pla-
cebo treatment ratio of a trial may affect placebo response.
Diener et al. examined the use of placebo in migraine tri-
als. They found that participants in clinical trials with a
greater active drug to placebo treatment ratio had a greater
placebo response due to a higher expectation of receiving
treatment [10].
Choosing an appropriate placebo treatment, sometimes
referred to as ~sham~treatment, is an obstacle when con-
ducting clinical trials with manipulative treatment. It is
difficult to develop a placebo that mimics osteopathic
manipulative treatment (OMT) or chiropractic treatment
and produces the expectation of benefit. A variety of pla-
cebo treatments such as light touch [11], sham manipula-
tion [12], and sub-therapeutic ultrasound [13] have been
used in manual therapy clinical trials. Vernon et al.
reported that after receiving a cervical sham manipula-
tion, study participants did not report clinically significant
changes in range of motion or tenderness. This study,
however, included 20 subjects of which only three had no
previous experience with chiropractic treatment [14].
Hawk et al. reported improvement in subjects with suba-
cute or chronic low back pain in both placebo and active
manipulation groups. There were no differences in the
amount of improvement between the groups, even after
controlling for prior chiropractic experience and initial
treatment expectations [15]. Furthermore, experts do not
necessarily agree on what constitutes the active compo-
nent of a treatment or placebo. In a recent study, a list of
10 placebo manipulative techniques (including a descrip-
tion of each) was developed and sent to experts in Aus-
tralia and New Zealand. At least one of the 16 respondents
replied that each technique had an active component, and
none of the techniques were considered an appropriate
placebo by at least 50% of the respondents [16]. To deter-
mine the credibility of light touch and sub-therapeutic
ultrasound as compared to High-Velocity Low-Amplitude
(HVLA) and standard of care, Slicho conducted a survey of
the general population. Survey respondents more stronglyOsteopathic Medicine and Primary Care 2007, 1:3 http://www.om-pc.com/content/1/1/3
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agreed with HVLA as a way to logically treat low back
pain, but responses did not differ in other aspects of treat-
ment expectation after reading a description of the treat-
ments [17].
Understanding the placebo effect and developing the best
placebo is vital to studying the effectiveness of OMT. This
current study was designed as a continuation of the
research conducted by Slicho [17]. Clinic patients were
asked to view a video of three types of treatments (one
active and two placebos) for chronic low back pain, and
responses for expectation of benefit from the treatments
were measured. The primary purpose of this research
study was to determine attitudes towards different types of
treatments commonly used in OMT clinical research tri-
als. A secondary question was whether or not these atti-
tudes are different if a person has previously received
OMT or chiropractic treatment.
Methods
This pilot study utilized a randomized, cross-over design.
Subjects 18 years of age and older were recruited from the
Family Medicine Clinic of the Texas College of Osteo-
pathic Medicine in Fort Worth, TX during February
through May 2005. Subjects were asked to participate in
the study while waiting for their regularly scheduled phy-
sician appointment. They were approached if their partic-
ipation would not interfere with clinic operations.
Participants were asked to watch a video with 2 minute
demonstrations representing a High-Velocity Low-Ampli-
tude (HVLA), placebo light touch (LT), and placebo sub-
therapeutic ultrasound (ULTRA) treatment for low back
pain. The HVLA treatment consisted of lateral recumbent
lumbar soft tissue treatment followed by a 'lumbar roll'
manipulation applied to both the left and right side of the
simulated patient. The LT treatment consisted of a series
of static bilateral hand placements on the posterior tho-
raco lumbar junction and upper pelvis followed by ante-
rior lower ribs and pelvis of the simulated patient. The
ULTRA treatment consisted of a close up image of the
ultrasound device followed by sequential application of
the non-functional ultrasound applicator (without gel) in
circular motions with mild pressure to the same anterior
and posterior bilateral body areas on the simulated
patient to which the light touch was applied. All treat-
ments were videotaped on the same day using the same
professionally dressed osteopathic physician and same
casually dressed simulated female patient. All treatments
were applied through the clothing. Treatments were
applied for 2 minutes with 1 minute allocated for each
side. All treatments required the simulated patient to lie
down, change sides, and return to a sitting position. The
simulated patient began and ended each treatment in the
sitting position facing the camera with the physician
standing behind her.
The order in which subjects viewed the demonstrations
was randomized to control for order effect bias. Six video
tapes were available to account for the different combina-
tions of treatments. The combinations were HVLA, LT,
ULTRA; HVLA, ULTRA, LT; ULTRA, HVLA, LT; ULTRA, LT,
HVLA; LT, HVLA, ULTRA; and LT, ULTRA, HVLA. A verbal
description of each treatment narrated by the same person
was included on the video, and a written description was
included on each survey. Subjects indicated the extent of
their agreement (using a 4 point Likert scale) with 4 state-
ments that were presented after each treatment was
viewed: 1. "I believe this treatment would allow me to get
better quicker"; 2. "I believe this treatment would decrease
my low back pain"; 3. "I believe this treatment would
make me more able to do the things I want to do"; 4. "This
seems like a logical way to treat low back pain" (Table 1).
Demographic information and previous experience with
osteopathic manipulative treatment, chiropractic treat-
ment, massage therapy, and ultrasound were collected;
however, a distinction was not made between previous
experience with diagnostic and therapeutic ultrasound.
Statistical analysis
Repeated measures analysis of variance (ANOVA) was
performed on each of the 4 questions to determine differ-
ences in responses for treatments. Post hoc analyses were
performed using Least Significant Difference (LSD). LSD
was used because of the pilot nature of the research study.
It does not adjust for the number of comparisons in the
post hoc analyses. A partial Eta squared (η2
p) was calcu-
lated for each of the 4 statements, representing the pro-
portion of the total variability accounted for by the test. A
Cohen's d (d) was calculated for the different possible
combinations of the four treatment presentations.
Cohen's d is an effect size calculated as (mean of treat-
ment group 1 – mean of treatment group 2)/the pooled
standard deviation. Throughout this manuscript, treat-
Table 1: Survey Statements*
S1 I believe this treatment would allow me to get better quicker.
S2 I believe this treatment would decrease my low back pain.
S3 I believe this treatment would make me more able to do the things I 
want to do.
S4 This seems like a logical way to treat low back pain.
* Responses were 1 = Strongly Agree, 2 = Agree, 3 = Disagree, 4 = Strongly DisagreeOsteopathic Medicine and Primary Care 2007, 1:3 http://www.om-pc.com/content/1/1/3
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ment group 1 and treatment group 2 are ordered as HVLA
and ULTRA; ULTRA and LT; or HVLA and LT. Cohen's d
values are considered to be a small effect size at 0.2, a
moderate effect size at 0.5, and a large effect size at 0.8
[18].
Participants responding "yes" to the question "Have you
ever had osteopathic manipulative treatment" or "Have
you ever had chiropractic treatment" were combined since
small numbers of respondents prevented meaningful sep-
aration for sub group analysis. Independent samples t
tests were performed for each question relating to the
ULTRA and LT groups to determine differences between
those having ever had manipulative treatment (osteo-
pathic or chiropractic) and those not having ever had
manipulative treatment.
Results were considered significant at the alpha 0.05 level.
All analyses were performed using SPSS 12.0 (SPSS Inc,
Chicago, IL). Study procedures were approved by the Uni-
versity of North Texas Health Science Center's Institu-
tional Review Board.
Results
Thirty of 40 eligible subjects participated for a 75%
response rate. Demographic characteristics of the sample
are presented in Table 2. Of the participants, 22 (73%)
were female, 16 (53%) were Caucasian, and 11 (37%)
had completed college. The mean age was 43 years (SD =
15, min = 20, max = 68). Ten (33.3%) subjects had previ-
ously experienced osteopathic manipulative treatment, 14
(46.7%) chiropractic treatment, 11 (36.7%) massage ther-
apy, and 20 (66.7%) ultrasound. Mean responses for each
question are presented in Table 3. The sphericity assump-
tion for repeated measures ANOVA was met for all ques-
tions.
Statement 1: "I believe this treatment would allow me to get
better quicker"
Repeated measures analyses of variance (ANOVA)
revealed an overall statistically significant difference in
responses between groups for Statement 1, (F(2,58) =
3.388, p = 0.041) (Table 4). Post hoc analysis identified
significant differences in responses between HVLA and LT
(p = 0.025) with a mean difference of -0.367 out of a max-
imum of 4. Participants responded more positively to the
statement "I believe this treatment would allow me to get
better quicker" for the HVLA treatment. There were no sta-
tistically significant differences between responses for
HVLA and ULTRA (p = 0.136) or between ULTRA and LT
(p = 0.231). The partial eta squared (η2
p) = 0.105.
Cohen's d (d) = -0.29 for HVLA and ULTRA; -0.21 for
ULTRA and LT; and -0.49 for HVLA and LT (Table 5). Each
of these represents a medium effect size between
responses for the treatment groups. The Cohen's d repre-
sents a borderline medium effect size for HVLA and
ULTRA and for ULTRA and LT; however, the there is a bor-
derline medium/large effect size for HVLA and LT.
Statement 2: "I believe this treatment would decrease my low
back pain"
Repeated measures ANOVA revealed no statistically sig-
nificant difference between responses to Statement 2, "I
believe this treatment would decrease my low back pain",
(F(2,58) = 2.257, p = 0.114) (Table 4). The partial eta
squared (η2
p) = 0.072.
Cohen's d (d) = -0.11 for HVLA and ULTRA; -0.31 for
ULTRA and LT; and -0.38 for HVLA and LT (Table 5). A
small effect is observed for HVLA and ULTRA. A medium
effect is observed for both ULTRA and LT; and HVLA and
LT, suggesting similar responses for each group.
Statement 3: "I believe this treatment would make me more
able to do the things I want to do"
Statistically significant differences were found between
responses for Statement 3, (F(2,58) = 3.485, p = 0.037)
with repeated measures ANOVA (Table 4). Post hoc anal-
ysis demonstrated significant differences between HVLA
and LT (p = 0.039) with a mean difference of -0.367 and
Table 2: Demographic characteristics of sample
n%
Gender
Male 8 26.7
Female 22 73.3
Race/Ethnicity
Caucasian 16 53.3
Hispanic 7 23.3
Other 7 23.3
Education
Some High School 5 16.7
High School 4 13.3
Some College 10 33.3
College 11 36.6
Ever Had Massage Therapy
Yes 11 36.7
No 19 63.3
Ever Had Osteopathic Manipulative Treatment
Yes 10 33.3
No 20 66.7
Ever Had Chiropractic Treatment
Yes 14 46.7
No 16 53.3
Ever Had Ultrasound
Yes 20 66.7
No 10 33.3Osteopathic Medicine and Primary Care 2007, 1:3 http://www.om-pc.com/content/1/1/3
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between HVLA and ULTRA (p = 0.048) with a mean dif-
ference of -0.300. Participants responded more positively
to the statement "I believe this treatment would make me
more able to do the things I want to do" for HVLA than
both the LT and ULTRA. There was not a statistically sig-
nificant difference between ULTRA and LT (p = 0.601).
The partial eta squared (η2
p) = 0.107.
Cohen's d (d) = -0.41 for HVLA and ULTRA; -0.09 for
ULTRA and LT; and -0.47 for HVLA and LT (Table 5). A
very small effect is observed for ULTRA and LT, while a
medium effect is observed for HVLA and ULTRA; and
HVLA and LT. This suggests similar responses for HVLA
and ULTRA and for HVLA and LT.
Statement 4: "This seems like a logical way to treat low back
pain"
Repeated measures ANOVA revealed no statistically sig-
nificant difference between responses to Statement 4,
"This seems like a logical way to treat low back pain",
(F(2,58) = 0.707, p = 0.497) (Table 4). The partial eta
squared (η2
p) = 0.024.
Cohen's d (d) = -0.21 for HVLA and ULTRA; 0 for ULTRA
and LT; and -0.19 for HVLA and LT (Table 5). There is no
effect observed for ULTRA and LT for this question and
only a small effect for HVLA and LT. A marginally medium
effect is observed for HVLA and ULTRA.
Manipulative treatment
A significant difference was observed between those hav-
ing ever received manipulative treatment (osteopathic
manipulative treatment or chiropractic treatment) and
those not having ever received manipulative treatment
when responding to Statement 1 for the ULTRA group (p
= 0.03). Those who had never received manipulative treat-
ment (mean = 1.83) responded more favourably than
those who had received manipulative treatment (mean =
2.39).
No other differences were found between having ever
received manipulative treatment and not having ever
received manipulative treatment for any other question
pertaining to either the ULTRA or LT treatments. However,
the difference did approach significance for Statement 4
with the ULTRA treatment (p = 0.06), also with those who
had never received manipulative treatment (mean = 1.83)
responding more favourably than those who had received
manipulative treatment (mean = 2.33).
A similar analysis of subjects who had never received
ultrasound and subjects who had received ultrasound was
conducted. No significant differences were observed
between the groups for any of the 4 statements relating to
HVLA or LT.
Discussion
This study aimed to measure treatment expectations of
patients in a Family Medicine clinic after watching a video
with short demonstrations of one active and two placebo
treatments that have all been used in previous clinical tri-
als of osteopathic manipulative treatment (OMT). In a
previous study, Slicho provided information on treatment
expectations of the general population measured through
a postal survey with descriptions representing High-Veloc-
Table 4: Repeated measures ANOVA and partial Eta squared*
FP η2
p
S1 3.388 0.041 0.105
S2 2.257 0.114 0.072
S3 3.485 0.037 0.107
S4 0.707 0.497 0.024
*P = p value; degrees of freedom = (2, 58); η2
p = Partial Eta Squared
Table 3: Mean responses to questions*
HVLA ULTRA LT
mean (SD) 95% CI mean (SD) 95% CI mean (SD) 95% CI
S1 1.97 (0.67) (1.72, 2.22) 2.17 (0.70) (1.91, 2.43) 2.33 (0.80) (2.03, 2.63)
S2 1.93 (0.69) (1.68, 2.19) 2.00 (0.59) (1.78, 2.22) 2.20 (0.71) (1.93, 2.47)
S3 1.93 (0.79) (1.64, 2.23) 2.23 (0.68) (1.98, 2.49) 2.30 (0.79) (2.00, 2.60)
S4 1.97 (0.81) (1.66, 2.27) 2.13 (0.73) (1.86, 2.41) 2.13 (0.86) (1.81, 2.45)
*SD = Standard Deviation; HVLA – High-Velocity Low-Amplitude; ULTRA = Sub-therapeutic Ultrasound; LT = Light TouchOsteopathic Medicine and Primary Care 2007, 1:3 http://www.om-pc.com/content/1/1/3
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ity Low-Amplitude (HVLA), sub-therapeutic ultrasound,
light touch, and standard care. Slicho found that study
participants more strongly agreed with HVLA as a way to
logically treat low back pain, but responses did not differ
for other aspects of treatment expectations [17]. In the
current study, participants were asked to respond to the
same statements after viewing two minute filmed demon-
strations of the treatments. The investigators realize a bet-
ter study design of measuring placebo effect would be to
have the participants experience the treatments. This
study, however, was conducted to provide pilot data on a
topic that is under-researched, but vital to successfully
conducting clinical trials of OMT. This represents an ele-
mentary step in identifying an appropriate placebo for
OMT clinical trials.
Analysis revealed a significant difference in participant
responses to the statement "I believe this treatment would
allow me to get better quicker" after viewing the three
treatments. Post hoc analysis demonstrated that partici-
pants responded more positively with the statement after
viewing the High-Velocity Low-Amplitude treatment than
after viewing the light touch treatment. There were no dif-
ferences between responses after viewing the High-Veloc-
ity Low-Amplitude and ultrasound treatments or between
ultrasound and light touch treatments.
There was also a significant difference between responses
for the statement "I believe this treatment would make me
more able to do the things I want to do." Again, post hoc
analysis revealed a difference existed in participant
responses after viewing the High-Velocity Low-Amplitude
treatment and the light touch treatment such that partici-
pants responded more positively with the High-Velocity
Low-Amplitude treatment. There were no other differ-
ences between responses to this statement. These results
suggest the sub-therapeutic ultrasound might be a more
suitable placebo than LT since there were significantly dif-
ferent expectations between the HVLA and the light touch
treatments, but not between HVLA and ultrasound.
Prior experience with manipulative treatment
The expectation of treatment and hence the placebo effect
may change with a person's previous experience with
manipulative treatment. In this study participants were
asked if they had ever had osteopathic manipulative treat-
ment or chiropractic treatment. Participants that had
received manipulative treatment (non-naïve) were com-
pared to participants who had never received manipula-
tive treatment (naïve) on all four statements. There were
differences between responses from naïve and non-naive
participants for the statement "I believe this treatment
would allow me to get better quicker," after viewing the
ultrasound treatment. Participants who were naïve to
manipulative treatment responded more favourably than
those who were non-naïve, suggesting that naïve partici-
pants had a greater expectation of treatment after viewing
the ultrasound treatment than did non-naïve participants.
The difference in responses between naïve and non-naïve
participants for the statement "This seems like a logical
way to treat low back pain" approached significance,
again suggesting that naïve participants may have had a
greater expectation of treatment after viewing the ultra-
sound treatment. No differences were found between
naïve and non-naïve participants after viewing the light
touch treatment for any of the statements. These results
suggest that differences in treatment expectations between
naïve and non-naïve research participants can have
important implications in selecting the appropriate pla-
cebo for manipulative treatment clinical trials. Research
study participants' experience with manipulative treat-
ment should be measured and controlled for through sta-
tistical analysis or controlled for in the study design.
Limitations
There are several limitations to this current study. First, a
convenience sample was utilized. Participates in this study
were patients in a Family Medicine clinic and were asked
to participate if they would be waiting at least 10 minutes
before being seen by their physician. This recruitment
process was used to ensure minimal interruption of clinic
operations. The use of a convenience sample minimizes
the generalizability of the study findings to the general
population. Second, participants were recruited from a
clinic associated with an osteopathic medical school. This
may further limit generalizability because patients at an
osteopathic medical school had self reported poorer
health than the general population [19]. However, this
Table 5: Effect Sizes (Cohen's d) for Each Statement for Treatment Groupings*
HVLA & ULTRA ULTRA & LT HVLA & LT
S1 -0.29 -0.21 -0.49
S2 -0.11 -0.31 -0.38
S3 -0.41 -0.09 -0.47
S4 -0.21 0 -0.19
*HVLA – High-Velocity Low-Amplitude; ULTRA = Sub-therapeutic Ultrasound;
LT = Light Touch.
Cohen's d – 0.2 small effect; 0.5 moderate effect; 0.8 large effect [18].Osteopathic Medicine and Primary Care 2007, 1:3 http://www.om-pc.com/content/1/1/3
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clinic population is representative of subjects commonly
used in OMT clinical research studies. Finally, study par-
ticipants did not experience the different treatments. This
study measured treatment expectations from watching a
short demonstration of the treatments. Actually experi-
encing the treatments would provide additional stimuli to
participants and potentially change their expectations.
Future research
This study is only an initial step in identifying the best pla-
cebo for OMT clinical trials. Measuring expectations of
benefits after viewing a two minute demonstration of a
treatment cannot replace measuring expectations of bene-
fits after actually receiving a treatment. Further research
into the placebo effect, particularly for manipulative treat-
ments, is needed. The most appropriate placebo for OMT
clinical trials cannot be truly determined until a better
understanding of treatment expectation, physician/
patient interaction in osteopathic medicine, other factors
involved in the placebo effect, and a patient's experience
with manipulative treatment is achieved. A point of inter-
est would be to determine if the amount of prior experi-
ence with manipulative treatment is correlated with
treatment expectations. Additionally, prior experience
with manipulative treatment may have different effects
across different countries with variations in OMT practi-
tioner training. The video demonstrations also do not
control for the effect of touch or sound during the treat-
ments. Actually applying the sub-therapeutic ultrasound
on the skin with gel could potentially change treatment
expectations. The presented results, however, provide an
elementary analysis of potential placebo treatments in
OMT clinical trials and provide the opportunity to seek
funding for more definitive research studies. The next step
is to research the way participants respond to these issues
after actually experiencing OMT and placebo treatments.
Conclusion
This pilot study presents valuable elementary information
for selecting an appropriate placebo when conducting
OMT clinical trials. Effect sizes between HVLA and two
possible placebo treatments are provided. These effect
sizes can be used to help determine sample size estima-
tions for future projects involving either a light touch or
sub-therapeutic ultrasound placebo group as compared to
an HVLA treatment group. Results of this pilot study sug-
gest that expectations of the sub-therapeutic ultrasound
placebo treatment are more similar to expectations of the
HVLA treatment. Thus, using a sub-therapeutic ultra-
sound placebo may allow for a more optimal opportunity
to identify a true treatment versus placebo effect. Addi-
tionally, it is important to control for prior experience
with the various treatments, as those who are not naïve to
manipulative treatment may have greater treatment
expectations. The authors recommend either excluding
subjects who have had OMT or chiropractic treatment or
at least using statistical analyses to control for potential
effects.
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